EQUITEST
Apparatus, Vestibular Analysis
NEUROCOM INTERNATIONAL, INC.
The following data is part of a premarket notification filed by Neurocom International, Inc. with the FDA for Equitest.
Pre-market Notification Details
| Device ID | K851744 |
| 510k Number | K851744 |
| Device Name: | EQUITEST |
| Classification | Apparatus, Vestibular Analysis |
| Applicant | NEUROCOM INTERNATIONAL, INC. 2326 NW LOVEJOY ST. P.O. BOX 12529 Portland, OR 97210 |
| Contact | Lewis M Nashner |
| Correspondent | Lewis M Nashner NEUROCOM INTERNATIONAL, INC. 2326 NW LOVEJOY ST. P.O. BOX 12529 Portland, OR 97210 |
| Product Code | LXV |
| CFR Regulation Number | 510(k) Premarket Notification [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 1985-04-29 |
| Decision Date | 1985-08-05 |
Trademark Results [EQUITEST]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 EQUITEST 90261594 not registered Live/Pending |
Nezikist Group LTD 2020-10-18 |
 EQUITEST 76418583 2785646 Live/Registered |
NATUS MEDICAL INCORPORATED 2002-06-07 |
 EQUITEST 73623045 1446204 Live/Registered |
NEUROCOM INTERNATIONAL, INC. 1986-09-26 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.